{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:19:19Z","timestamp":1787681959077,"version":"build-2784847793"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"DFG through the Leibniz Award 2023"},{"name":"Collaborative Research Center","award":["1483 1755"],"award-info":[{"award-number":["1483 1755"]}]},{"name":"Transregio 369"},{"DOI":"10.13039\/100012051","name":"Lupus Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005295","name":"Staedtler Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005295","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Women with SLE are at increased risk of infertility due to disease activity and exposure to gonadotoxic therapies. Anti\u2011CD19 chimeric antigen receptor (CAR) T\u2011cell therapy has recently been shown to induce durable, drug\u2011free remission in refractory SLE; however, its effects on ovarian function remain unknown. We assessed longitudinal changes in reproductive endocrine markers to evaluate the impact of CAR T\u2011cell therapy on ovarian reserve and hypothalamic\u2013pituitary\u2013ovarian (HPO) axis function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Women with severe, treatment\u2011refractory SLE receiving autologous anti\u2011CD19 CAR T\u2011cell therapy (Miltenyi Biomedicine) in conjunction with standard lymphodepletion at two tertiary care centres were studied. Anti\u2011M\u00fcllerian hormone (AMH), oestradiol (E2), progesterone, follicle\u2011stimulating hormone (FSH), luteinizing hormone (LH) and prolactin were measured at baseline and 12\u202fmonths after therapy. Blood samples were obtained independent of menstrual cycle phase. Paired statistical analyses were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirteen women were included; median age at CAR T\u2011cell therapy was 27\u202fyears. AMH levels were stable (1.54\u202fng\/ml [IQR 0.64\u20133.15] vs 2.14\u202fng\/ml [0.63\u20133.26]; P\u2009=\u20090.886). E2 (243\u202fpmol\/l [186\u2013346] vs 484\u202fpmol\/l [277\u2013829]; P\u2009=\u20090.339) and progesterone (0.90\u202fnmol\/l [0.80\u20130.90] vs 1.80\u202fnmol\/l [0.90\u20133.40]; P\u2009=\u20090.054) showed substantial variability without significant longitudinal change. FSH increased modestly (6.60\u202fIU\/l [4.00\u20137.90] vs 7.20\u202fIU\/l [4.50\u20139.90]; P\u2009=\u20090.033) without a concomitant decline in AMH. LH (6.10\u202fIU\/l [5.10\u201312.90] vs 7.00\u202fIU\/l [5.00\u201312.90]; P\u2009=\u20090.946) and prolactin (10.0\u202f\u00b5g\/l [8.0\u201310.0] vs 8.0\u202f\u00b5g\/l [5.0\u20139.0]; P\u2009=\u20090.123) remained stable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Anti\u2011CD19 CAR T\u2011cell therapy, including standard lymphodepletion, showed no signal of impaired ovarian reserve, as assessed by AMH and hormone profiles. Observed hormonal changes, including FSH, should be interpreted with caution given study limitations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keag413","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:46:32Z","timestamp":1786535192000},"source":"Crossref","is-referenced-by-count":0,"title":["Hormone levels of female patients with SLE after anti-CD19 CAR T-cell treatment do not indicate a signal of impaired ovarian reserve"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0201-0686","authenticated-orcid":false,"given":"Ann-Christin","family":"Pecher","sequence":"first","affiliation":[{"name":"Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital T\u00fcbingen , T\u00fcbingen,","place":["Germany"]},{"name":"Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital T\u00fcbingen , T\u00fcbingen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8385-6861","authenticated-orcid":false,"given":"J\u00f6rg","family":"Henes","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital T\u00fcbingen , T\u00fcbingen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8844-5922","authenticated-orcid":false,"given":"Melanie","family":"Henes","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s Health, University of T\u00fcbingen , T\u00fcbingen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5442-2805","authenticated-orcid":false,"given":"Claudia","family":"Lengerke","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital T\u00fcbingen , T\u00fcbingen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6052-2618","authenticated-orcid":false,"given":"Wolfgang","family":"Bethge","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital T\u00fcbingen , T\u00fcbingen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Wirsching","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen,","place":["Germany"]},{"name":"Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4190-5005","authenticated-orcid":false,"given":"Tobias","family":"Rothe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen,","place":["Germany"]},{"name":"Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5487-5839","authenticated-orcid":false,"given":"Fabian","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen,","place":["Germany"]},{"name":"Department of Internal Medicine 5\u2014Hematology and Oncology, University Hospital of Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0685-4483","authenticated-orcid":false,"given":"Andreas","family":"Mackensen","sequence":"additional","affiliation":[{"name":"Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen,","place":["Germany"]},{"name":"Department of Internal Medicine 5\u2014Hematology and Oncology, University Hospital of Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8740-9615","authenticated-orcid":false,"given":"Georg","family":"Schett","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen,","place":["Germany"]},{"name":"Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1190-1384","authenticated-orcid":false,"given":"Melanie","family":"Hagen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen,","place":["Germany"]},{"name":"Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"2026082513285133900_keag413-B1","doi-asserted-by":"crossref","first-page":"103038","DOI":"10.1016\/j.autrev.2022.103038","article-title":"Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis","volume":"21","author":"Giambalvo","year":"2022","journal-title":"Autoimmun Rev"},{"key":"2026082513285133900_keag413-B2","doi-asserted-by":"crossref","first-page":"1132045","DOI":"10.3389\/fimmu.2023.1132045","article-title":"A new insight into the impact of systemic lupus erythematosus on oocyte and embryo development as well as female fertility","volume":"14","author":"Mao","year":"2023","journal-title":"Front Immunol"},{"key":"2026082513285133900_keag413-B3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/molehr\/gaz020","article-title":"Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes","volume":"25","author":"Nguyen","year":"2019","journal-title":"Mol Hum Reprod"},{"key":"2026082513285133900_keag413-B4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMcp2311150","article-title":"Infertility evaluation and treatment","volume":"392","author":"Santoro","year":"2025","journal-title":"N Engl J Med"},{"key":"2026082513285133900_keag413-B5","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/s41591-025-04185-6","article-title":"CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1\/2 CASTLE basket trial","volume":"32","author":"Muller","year":"2026","journal-title":"Nat Med"},{"key":"2026082513285133900_keag413-B6","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","article-title":"Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide","volume":"46","author":"Houssiau","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2026082513285133900_keag413-B7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/0961203308094652","article-title":"Menstrual and hormonal alterations in juvenile systemic lupus erythematosus","volume":"18","author":"Medeiros","year":"2009","journal-title":"Lupus"},{"key":"2026082513285133900_keag413-B8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/OGX.0000000000000160","article-title":"Ovarian function and reproductive outcomes of female patients with systemic lupus erythematosus and the strategies to preserve their fertility","volume":"70","author":"Oktem","year":"2015","journal-title":"Obstet Gynecol Surv"},{"key":"2026082513285133900_keag413-B9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.fertnstert.2011.10.031","article-title":"A characterization of the relationship of ovarian reserve markers with age","volume":"97","author":"Rosen","year":"2012","journal-title":"Fertil Steril"},{"key":"2026082513285133900_keag413-B10","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1210\/jc.2017-00131","article-title":"Functional hypothalamic amenorrhea: an Endocrine Society Clinical Practice Guideline","volume":"102","author":"Gordon","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026082513285133900_keag413-B11","first-page":"393","article-title":"The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women","volume":"8","author":"Barbakadze","year":"2015","journal-title":"Int J Fertil Steril"},{"key":"2026082513285133900_keag413-B12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1200\/JCO.2021.39.15_suppl.552","article-title":"Use of a high-sensitivity anti-Mullerian hormone (AMH) assay to determine ovarian function after chemotherapy for early breast cancer","volume":"39","author":"Clatot","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026082513285133900_keag413-B13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13075-020-02292-y","article-title":"Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study","volume":"22","author":"Sharma","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2026082513285133900_keag413-B14","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.fertnstert.2024.12.016","article-title":"Low doses of alkylating agents do not harm human ovarian tissue destined for cryopreservation","volume":"123","author":"Houeis","year":"2025","journal-title":"Fertil Steril"},{"key":"2026082513285133900_keag413-B15","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.fertnstert.2020.11.040","article-title":"Ovaries of patients recently treated with alkylating agent chemotherapy indicate the presence of acute follicle activation, elucidating its role among other proposed mechanisms of follicle loss","volume":"115","author":"Shai","year":"2021","journal-title":"Fertil Steril"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keag413\/70617749\/keag413.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/8\/keag413\/70617749\/keag413.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/8\/keag413\/70617749\/keag413.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:28:59Z","timestamp":1787678939000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keag413\/8759539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keag413","relation":{},"ISSN":["1462-0332"],"issn-type":[{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8,1]]},"article-number":"keag413"}}